Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Does treatment with beta-adrenergic blocking agents cause a decrease in beta 2-adrenoceptor affinity?

W M Blankesteijn1, S J Graafsma, M P Hectors

  • 1Department of General Internal Medicine, St Radboud University Hospital, The Netherlands.

European Journal of Clinical Pharmacology
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of selective TNFR1 inhibition or TNFR2 stimulation, compared to non-selective TNF inhibition, on (neuro)inflammation and behavior after myocardial infarction in male mice.

Brain, behavior, and immunity·2021
Same author

[Somatic disorders in outpatient psychiatry: the added value of a standard physical examination during the intake of outpatients].

Tijdschrift voor psychiatrie·2014
Same author

The Wnt/Frizzled pathway as a therapeutic target for cardiac hypertrophy: where do we stand?

Acta physiologica (Oxford, England)·2011
Same author

A systematic review on the influence of trial quality on the effect of garlic on blood pressure.

The Netherlands journal of medicine·2009
Same author

[No response to antihypertensive therapy: consider non-adherence].

Nederlands tijdschrift voor geneeskunde·2007
Same author

The case for case reports in the Netherlands Journal of Medicine.

The Netherlands journal of medicine·2006

Beta-adrenoceptor antagonists (BAAs) decrease the affinity of beta 2-adrenoceptors for antagonists, regardless of lipophilicity or partial agonist activity (PAA). This finding may explain the complex relationship between BAA kinetics and dynamics.

Area of Science:

  • Pharmacology
  • Cardiovascular Research
  • Adrenoceptor Biology

Background:

  • Beta-adrenoceptor antagonists (BAAs) are widely used cardiovascular drugs.
  • Their lipophilicity and partial agonist activity (PAA) influence their clinical effects.
  • Understanding their interaction with beta 2-adrenoceptors is crucial for optimizing therapy.

Purpose of the Study:

  • To investigate the effect of BAAs with varying lipophilicity and PAA on the dissociation constant (KD) of [125I]-(-)-iodocyanopindolol binding to beta 2-adrenoceptors.
  • To determine the impact of BAAs and a full agonist on beta 2-adrenoceptor characteristics in healthy volunteers.

Main Methods:

  • A cross-over study design involving twelve healthy male volunteers.
  • Administration of propranolol, pindolol, dilevalol (BAAs), and salbutamol (full agonist).

Related Experiment Videos

  • Measurement of blood pressure, heart rate, and mononuclear leukocyte (MNL) beta 2-adrenoceptor characteristics (KD and density) before and after single doses and 8-day courses.

    • Main Results:

    • All BAAs decreased blood pressure; only propranolol reduced heart rate.
    • Salbutamol altered blood pressure and heart rate without affecting receptor affinity.
    • BAAs increased the KD for antagonist binding to beta 2-adrenoceptors by up to 3.7-fold after 8 days.
    • BAAs and salbutamol decreased beta 2-adrenoceptor density by 30%.

    Conclusions:

    • BAA treatment reduces the affinity of MNL beta 2-adrenoceptors for antagonists, irrespective of lipophilicity or PAA.
    • This change in receptor affinity may elucidate the discrepancies between BAA kinetics and dynamics.
    • Salbutamol, a full agonist, did not alter receptor affinity, highlighting a distinct mechanism of action.